Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.
Gameto’s lead asset is a cell-based IVM tool, Fertilo, which is currently in late-stage development within the US.
Astellas will continue development of DAX-044, which is expected to enter Phase I in 2027. Credit: Lightspring / Shutterstock.com. Astellas Pharma has inked a billion-dollar licensing deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results